| Stephen H Culp, MD | |
|
500 Ray C Hunt Dr, Charlottesville, VA 22903-2981 | |
| (434) 924-2224 | |
| (434) 244-9481 |
| Full Name | Stephen H Culp |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 22 Years |
| Location | 500 Ray C Hunt Dr, Charlottesville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194830091 | NPI | - | NPPES |
| 219921801 | Other | TX | MEDICAID TPI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | M9232 (Texas) | Secondary |
| 208800000X | Urology | 0101249368 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Novant Health Uva Health System Culpeper Med Cente | Culpeper, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Virginia Physicians Group | 4880590728 | 1397 |
News Archive
The Queensland Institute of Medical Research (QIMR) Australia, is working on a vaccine to prevent rheumatic fever (RF) and rheumatic heart disease (RHD). Rheumatic fever and rheumatic heart disease are a secondary complication of a bacterial infection.
Obesity, especially excessive belly fat, is a risk factor for chronic obstructive pulmonary disease (COPD), according to an article in CMAJ (Canadian Medical Association Journal).
Cell Therapeutics, Inc. (CTI) today announced that the Gynecologic Oncology Group (GOG) informed CTI that an independent Data Safety Monitoring Board (DSMB) recommended continuation of the GOG-0212 Phase 3 clinical trial of OPAXIOTM (paclitaxel poliglumex) as maintenance therapy in ovarian cancer with no changes following a planned interim survival analysis.
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
| Entity Name | University Of Virginia Physicians Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033138250 PECOS PAC ID: 4880590728 Enrollment ID: O20040102000780 |
News Archive
The Queensland Institute of Medical Research (QIMR) Australia, is working on a vaccine to prevent rheumatic fever (RF) and rheumatic heart disease (RHD). Rheumatic fever and rheumatic heart disease are a secondary complication of a bacterial infection.
Obesity, especially excessive belly fat, is a risk factor for chronic obstructive pulmonary disease (COPD), according to an article in CMAJ (Canadian Medical Association Journal).
Cell Therapeutics, Inc. (CTI) today announced that the Gynecologic Oncology Group (GOG) informed CTI that an independent Data Safety Monitoring Board (DSMB) recommended continuation of the GOG-0212 Phase 3 clinical trial of OPAXIOTM (paclitaxel poliglumex) as maintenance therapy in ovarian cancer with no changes following a planned interim survival analysis.
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephen H Culp, MD Po Box 9007, Charlottesville, VA 22906-9007 Ph: () - | Stephen H Culp, MD 500 Ray C Hunt Dr, Charlottesville, VA 22903-2981 Ph: (434) 924-2224 |
News Archive
The Queensland Institute of Medical Research (QIMR) Australia, is working on a vaccine to prevent rheumatic fever (RF) and rheumatic heart disease (RHD). Rheumatic fever and rheumatic heart disease are a secondary complication of a bacterial infection.
Obesity, especially excessive belly fat, is a risk factor for chronic obstructive pulmonary disease (COPD), according to an article in CMAJ (Canadian Medical Association Journal).
Cell Therapeutics, Inc. (CTI) today announced that the Gynecologic Oncology Group (GOG) informed CTI that an independent Data Safety Monitoring Board (DSMB) recommended continuation of the GOG-0212 Phase 3 clinical trial of OPAXIOTM (paclitaxel poliglumex) as maintenance therapy in ovarian cancer with no changes following a planned interim survival analysis.
New research led by investigators at Massachusetts General Hospital and Massachusetts Eye and Ear indicates that the blood pressure drug losartan may benefit patients with neurofibromatosis type 2 (NF2), a hereditary condition associated with vestibular schwannomas, or noncancerous tumors along the nerves in the brain that are involved with hearing and balance.
CAS Medical Systems, Inc. today announced that six abstracts featuring the use of the FORE-SIGHT Absolute Oximeter were presented at the Pediatric Academic Societies meeting May 1-4 in Vancouver, BC, Canada. This meeting includes more than 7,500 leaders in academic pediatrics and is dedicated to the advancement of pediatric research and the advanced care of acutely ill children.
› Verified 4 days ago
Dr. Kirsten Greene, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-244-9481 | |
Mikel Gray, N.P. Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr Fl 3, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-982-3652 | |
Jacqueline Marie Zillioux, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-244-9481 | |
Ryan P. Smith, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 500 Ray C Hunt Dr, Charlottesville, VA 22903 Phone: 434-924-2224 Fax: 434-982-3652 | |
Adel B. Guirguis, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: Uva Hospital W, Hospital Drive, Charlottesville, VA 22908 Phone: 434-924-2224 Fax: 434-243-6878 | |
Dr. Frazier T Fortenberry Jr., MD Urology Medicare: Accepting Medicare Assignments Practice Location: 630 Peter Jefferson Pkwy, Suite 135, Charlottesville, VA 22911 Phone: 434-244-5722 Fax: 434-244-5723 |